GlassScriptPhysician profile
Loreen Omoore
NPI 1306392345
$2,366.17
in general payments reported to CMS, 2019-2025
24 companies · $15.82 in 2025
The $15.82 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,543 · 2022: $431 · 2023: $377 · 2025: $15.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.67 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $406.79 | 2021-2022 | |
| Merz North America, INC. | $345.27 | 2023 | Xeomin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.04 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $217.33 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $133.52 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.56 | 2021-2022 | |
| United Therapeutics Corporation | $115.70 | 2021-2022 | |
| Mylan Specialty L.P. | $97.96 | 2021-2022 | |
| Advanced Respiratory, INC | $77.51 | 2021 | |
| Astellas Pharma US INC | $67.61 | 2021 | |
| Amarin Pharma, INC. | $60.89 | 2021 | |
| Mallinckrodt Hospital Products INC. | $60.24 | 2021-2022 | |
| Electromed, INC. | $49.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $43.69 | 2021-2022 | |
| Grifols USA, LLC | $37.06 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $30.65 | 2021-2022 | |
| Abbott Laboratories | $28.84 | 2023-2025 | Freestyle Libre 3, Mitraclip |
| Baxter Healthcare | $21.85 | 2022 | |
| Nestle Healthcare Nutrition INC. | $21.40 | 2021 | |
| Gilead Sciences, INC. | $20.25 | 2022 | |
| Genzyme Corporation | $19.89 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.67 | 2021 | |
| Boston Scientific Corporation | $18.45 | 2023 | |
| Insmed, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loreen Omoore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.